The U.S. Food and Drug Administration amended the emergency use authorization for the Moderna COVID-19 vaccine to shorten the interval between primary vaccination and boosters to five months.
FDA shortens Moderna booster time to five months
The U.S. Food and Drug Administration amended the emergency use authorization for the Moderna COVID-19 vaccine to shorten the interval between primary vaccination and boosters to five months.
